Effect of neurological dysfunction on health-related quality of life in patients with high-grade glioma

Journal of Neuro-Oncology

Volumn 34, Issue 3, 1997, Pages 263-278

  Osoba, D ^a,h   Aaronson, N K ^b   Muller, M ^b   Sneeuw, K ^b   Hsu, M A ^c,d   Yung, W K A ^e   Brada, M ^f   Newlands, E ^g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c MERCK RESEARCH LABORATORIES   (United States)

^d PFIZER INC   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f ROYAL MARSDEN HOSPITAL   (United Kingdom)

^g CHARING CROSS HOSPITAL   (United Kingdom)

^h BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

BCM20; Brain cancer; Karnofsky Performance Status; QLQ C30; Quality of life

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; COGNITION; DAILY LIFE ACTIVITY; DYSPHASIA; EMOTION; FATIGUE; FEMALE; GLIOBLASTOMA; HUMAN; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MOTOR DYSFUNCTION; MUSCLE WEAKNESS; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL INTERACTION; SYMPTOM; URINE INCONTINENCE; VISUAL DISORDER;

ADOLESCENT; ADULT; APHASIA; BRAIN NEOPLASMS; CONFUSION; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HEALTH STATUS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NERVOUS SYSTEM DISEASES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0030761590     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005790632126     Document Type: Article

References (34)

1. McKeran RO, Thomas DGT: The clinical study of gliomas. In: Thomas DGT, Graham DI (eds) Brain Tumours: Scientific Basis, Clinical Investigation and Current Therapy. 194-230, 1980
2. Archibald YM, Lunn D, Ruttan LA, Macdonald DR, Del Maestro RF, Barr HW, Pexman JH, Fisher BJ, Gasper LE, Cairncross JG: Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 80: 247-253, 1994
3. Taphoorn MJB, Heinmans JJ, Snoek FJ, Lindeboom J, Oosterink B, Wolbers JG, Karim ABMF: Assessment of quality of life in patients treated for low-grade glioma: a preliminary report. J Neurol Neurosurg Psychiat 55: 372-376, 1992
4. Grant R, Slattery J, Gregor A, Whittle IR: Recording neurological impairment in clinical trials of glioma. J Neuro-Oncol 19: 37-39, 1994
5. Mackworth N, Fobair P, Prados MD: Quality of life self-reports from 100 brain tumor patients: comparisons with Karnofsky performance scores. J Neuro-Oncol 14: 243-253, 1992
6. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavri D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international trials in oncology. J Natl Cancer Inst 85: 365-376, 1993
7. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH: The use of nitrogen mustards in palliative treatment of carcinoma. Cancer 1: 634-656, 1948
8. McDowell I, Newell C: Measuring Health: A Guide to Rating Scales and Questionnaires. The Barthel Index. Oxford, Oxford University Press 49-54, 1987
9. Osoba D, Aaronson NK, Muller M, Sneeuw K, Hsu M-A, Yung WKA, Brada M, Newlands E: The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139-150, 1996
10. Osoba D: The Quality of Life Committee of the Clinical Trials Group of the National Institute of Canada: organization and functions. Qual Life Res 1: 211-218, 1992
11. Bergman B, Sullivan M, Sörenson S: Quality of life during chemotherapy for small cell lung cancer. II. A longitudinal study of the EORTC Core Quality of Life Questionnaire and comparison with the Sickness Impact Profile. Acta Oncol 3119-3128, 1992
12. Bjordal K, Kaasa S: Psychometric validation of the EORTC Core Quality of Life Questionnaire, a 30-item version and a diagnosis-specific module for head and neck cancer patients. Acta Oncol 31: 311-321, 1992
13. Osoba D, Zee B, Pater J, Warr D, Kaizer L, Latreille J: Psychometric properties and responsiveness of EORTC Quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer. Qual Life Res 3: 353-364, 1994
14. Niezgoda HE, Pater JL: A validation study of the domains of the core EORTC Quality of Life Questionnaire. Qual Life Res 2: 215-319, 1993
15. Ringdal GI, Ringdal K: Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2:129-140, 1993
16. Sigurdardottir V, Bolund C, Brandberg Y, Sullivan M: The impact of generalized malignant melanoma on quality of life evaluated by the EORTC questionnaire technique. Qual Life Res 2:193-203, 1993
17. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S: Test-retest study of the European Organization for Research Treatment Core Quality-of-Life Questionnaire. J Clin Oncol 13: 1249-1254, 1995
18. Wisloff F, Ecka S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J: Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group. Br J Haematol 92: 604-613, 1996
19. Kaasa S, Bjordal K, Aaronson N, Mourn T, West E, Hagen S, Kvitstad A: The EORTC Core Quality of Life Questionnaire (QLQ- C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 31A: 2260-2263, 1995
20. Groenvold M, Bjorner JB, Klee M, Kreiner S: Test for item bias in a quality of life questionnaire. J Clin Epidemiol 48: 805-816, 1995
21. Schaafsma J, Osoba D : The Karnofsky performance status scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res 3:413-424, 1994
22. Sadura A, Pater J, Osoba D, Levine M, Palmer M, Bennet K: Quality-of-life assessment: patient compliance with questionnaire completion. J Natl Cancer Inst 84:1023-1026, 1992
23. Osoba D, Dancey J, Zee BC, Myles J, Pater J: Health-related quality-of-life studies of the National Cancer Institute of Canada Clinical Trials Group. Monogr Natl Cancer Inst 20: 107-111, 1996
24. Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 16: 297-334, 1951
25. Steel RGD, Torrie JH: Principles and Procedures of Statistics. 2nd ed. McGraw-Hill, New York, 1960
26. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Cella DF, Levin VA: The Functional Assessment of Cancer Therapy (FACT) Scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumours. Cancer 75:1151-1161, 1995
27. Osoba D, Aaronson N, Zee B, te Velde A, Sprangers M: Modification of the EORTC QLQ-C30 based on reliability testing in large samples of patients with cancer. Qual Life Res 4: 468, 1995 (abstract)
28. Schipper H, Clinch J, McMurray A, Levitt M:Measuring the quality of life of cancer patients:the Functional Living Index - Cancer: development and validation. J Clin Oncol 2:472-483, 1984
29. Coscarelli Schag CA, Ganz PA, Heinrich RL: Cancer Rehabilitation Evaluation system - Short Form (CARES-SF). A cancer specific rehabilitation and quality of life instrument. Cancer 68: 1406-1413, 1991
30. Selby PJ, Chapman J-AW, Etazadi-Amoli J: The development of a method for assessing quality of life in cancer patients. Br J Cancer 50: 13-22, 1984
31. Morrow GR, Lindke J, Black P: Measurement of quality of life in patients: psychometric analyses of the Functional Living Index-Cancer (FLIC). Qual Life Res 1: 287-296, 1992
32. Bliss JM, Selby PJ, Robertson B, Powles TJ: A method for assessing the quality of life of cancer patients: replication of the factor structure. Br J Cancer 65: 961-966, 1992
33. Sneeuw KCA, Aaronson NK, Osoba D, Muller MJ, Hsu M-A, Yung WKA, Brada M, Newlands ES: The use of significant others as proxy raters of the quality of life of patients with brain cancer. Qual Life Res 4: 486, 1995 (abstract)
34. Sneeuw KCA, Aaronson NK, Osoba D, Muller MJ, Hsu M-A, Yung WKA, Brada M, Newlands ES: The use of significant others as proxy raters of the quality of life of patients with brain cancer. Med Care 1996, in press